|
(b)(6): the nexsite device was placed successfully on (b)(6) 2016.At her 90 day review on (b)(6) 2016, there was no report of any adverse event.On (b)(6) 2016, the patient presented to the emergency department complaining of chest pain to touch and drainage from her dialysis port on the right side of her chest.Patient describes her port to be "oozing and painful" and also complains of chills and vomiting green fluids.She admits to missing her most recent dialysis appointments due to a fever following a flu shot 4-5 days ago.On examination of the skin, serous fluid with bloody tinge, slightly purulent drainage with moderate swelling and mild erythema to right chest dialysis port was reported.Pus was expressed from around the port and swabbed and sent for culture.(b)(6) was reported in the wound culture.This patient had a history of skin (b)(6).Blood cultures were also obtained but these results are not available.No action was taken with the study device.Given the lack of fever, the patient being relatively well-appearing and the white count being only 13.1, empiric treatment with invanz was recommended.Doxcycline was started on (b)(6) 2016.Lasix was also given to decrease her potassium.At the patient's day 120 review on (b)(6) 2016, an exit site infection was confirmed as occuring on (b)(6) 2016.A crbsi event was not confirmed.The patient is currently in the hospital with an infection, but no records have not been sent yet.
|